BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Vaxxinity Announces Board Appointments and Establishes New Headquarters in Florida

  Vaxxinity, Inc., a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, announced new appointments to the Board of Directors and the relocation of its corporate headquarters to Cape Canaveral, Fla.

  February 1, 2023

   · 

  5 min read
• Biotech Bay

  Bolt Biotherapeutics to Present at February 2023 Investor Conferences

  Bolt Biotherapeutics, a clinical-stage biopharmaceutical company developing novel immuno-oncology therapeutics for the treatment of cancer, announced that management will participate in two upcoming conferences in February.

  February 1, 2023

   · 

  1 min read
• Dxcover Raises $11.9m in Series A and Grant Funding to Accelerate Liquid Biopsy to Market

  Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, announced it has raised $11.9 million in Series A and grant financing.

  February 1, 2023

   · 

  2 min read
• Business

  Frazier Life Sciences Adds Highly Experienced T Cell Immunologist to Team

  Frazier Life Sciences announced the addition of Bryan A. Irving, Ph.D. as a Senior Advisor.

  February 1, 2023

   · 

  2 min read
• Pharm Country

  Sonnet BioTherapeutics Announces Successful Completion of Two IND-Enabling Toxicology Studies with SON-1210 in Non-Human Primates

  Sonnet BioTherapeutics Holdings, Inc. announced today that two IND-enabling toxicology studies have been completed in non-human primates (NHPs) using its lead bifunctional therapeutic candidate.

  February 1, 2023

   · 

  6 min read
• Sequana Medical announces grant of additional DSR® patent in United States

  Ghent, Belgium – 1 February 2023– Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces the grant of an additional US patent for its DSR program.

  February 1, 2023

   · 

  4 min read
• Business

  Occlutech Announces Change to the Executive Management Team

  Occlutech Holding AG Occlutech Holding AG, one of the world’s leading providers of minimally invasive structural heart disease devices, appoints Dr. Morwan Choli as the new Vice President of Regulatory Affairs & Quality.

  February 1, 2023

   · 

  2 min read
• BioCapital

  Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

  Sirnaomics Ltd. announced that it is advancing the clinical development of STP705 for the treatment of two non-melanoma skin cancers: Squamous Cell Carcinoma in situ and Basal Cell Carcinoma.

  February 1, 2023

   · 

  4 min read
• Policy

  Ellipses Pharma Announces FDA Approval of IND Application for EP0042 for Patients With Acute Myeloid Leukaemia

  Ellipses Pharma announces that the U.S. Food and Drug Administration has cleared the company’s Investigational New Drug application for EP0042, a dual FLT-3 and Aurora kinase inhibitor.

  February 1, 2023

   · 

  4 min read
• MIP Discovery Secures Significant Funding to Support Development of Global Rapid Response Diagnostics

  MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP™ technology, has announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation.

  February 1, 2023

   · 

  2 min read